MD, currently employed as a PhD student at Herlev-Gentofte hospital
Joined April 2022
- Tweets5
- Following35
- Followers39
- Likes13
Camilla Fuchs Andersen retweeted
OPEN ACCESS: Empagliflozin to elderly and obese patients with increased risk of developing heart failure: Study protocol for the Empire Prevent trial program
pubmed.ncbi.nlm.nih.gov/3836…
#Cardiology
Camilla Fuchs Andersen retweeted
The Empire Prevent trial program marks the first step towards elucidating the potential of SGLT2 inhibition for HF prevention 🫀🫀
Further reading: pubmed.ncbi.nlm.nih.gov/3836…
@CardResearchOuh @HGHHjerte @RigsHeart @jhempelheart @FuchsAndersen @mortschou
Camilla Fuchs Andersen retweeted
Empire Prevent 🩵🩷 includes patients in Odense @CardResearchOuh and Copenhagen @HGHHjerte. We greatly appreciate our collaboration with @SDCOdense and @RigsHeart 🩵🩷
Camilla Fuchs Andersen retweeted
Patient #100 randomized in Empire Prevent
Empagliflozin to elderly and obese patients with cardiovascular disease (Empire Prevent): a randomized controlled trial.
Collaboration between @CardResearchOuh and @HGHHjerte.
Camilla Fuchs Andersen retweeted
#HeartFailureAwarenessDays 2022!
Information campaign today at Herlev Hospital.
Conversations with visitors and employees. Focus on contacting your doctor and getting examined in case of suspect symptoms.
#HFAESC @HFA_President
@NinaNouhravesh @FuchsAndersen Lærke Nelson
